Jian Irish
Equibles does not estimate personal net worth.
Get an email with a short summary when Metagenomi Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get MGX alertsAbout Jian Irish
Jian Irish is recorded as COO, CEO and Board Member at Metagenomi Therapeutics, Inc. (MGX). The newest filing on record that lists Jian Irish as CEO and Board Member at Metagenomi Therapeutics, Inc. (MGX) is dated April 27, 2026. The newest filing on record that lists Jian Irish as COO at Metagenomi Therapeutics, Inc. (MGX) is dated April 28, 2025. The proxy statement of Metagenomi Therapeutics, Inc. reports total compensation of $1,667,920 for Jian Irish in fiscal 2025, including a base salary of $570,655. Disclosed compensation is on record for 3 fiscal years. Metagenomi Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Metagenomi Therapeutics, Inc. includes Pamela Wapnick (CFO), Matthew L. Wein (General Counsel), Eric Bjerkholt (Board Member) and 5 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2025
-
Current
Start not stated–present
Last confirmed April 27, 2026
-
Current
Start not stated–present
Last confirmed April 27, 2026
Company network
Leadership on record at Metagenomi Therapeutics, Inc.
- Pamela Wapnick CFO
- Matthew L. Wein General Counsel
- Eric Bjerkholt Board Member
- Eric Bjerkholt, M.B.A. Board Member
- Juergen Eckhardt Board Member
- Juergen Eckhardt, M.D., M.B.A. Board Member
- Laurence Reid Board Member
- Willard H. Dere Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Metagenomi Therapeutics, Inc. (MGX) | Ph.D., M.B.A. President and Chief Executive Officer | $570,655 | $1,667,920 |
| 2024 | Metagenomi Therapeutics, Inc. (MGX) | Ph.D., M.B.A. President and Chief Operating Officer | $536,333 | $3,783,435 |
| 2023 | Metagenomi Therapeutics, Inc. (MGX) | Ph.D., M.B.A. President and Chief Operating Officer | $465,000 | $2,513,028 |
Recent activity
No call appearances or filed executive changes recorded yet.